An increased level of PSMB4 has been observed in several solid cancers such as breast cancer, ovarian cancer, multiple myeloma, pulmonary neuroendocrine tumors and glioblastoma 58-63. Here, PSMB4 is linked to lung neuroendocrine neoplasm.